🔗 Share this article

A shadow market for unlicensed weight-loss drugs is propelled by social media fitness personalities and vendors on messaging platforms, according to recent findings.

Investigational Drug Acquiring Popularity Online

Retatrutide, which is still in clinical trials, is being promoted by online personalities for its alleged weight-reducing effects. Followers are urged to message these profiles privately for supplier links, while also obtaining promotional offers.

Active Trade on Social Networks

Additionally, a robust trade exists on Telegram, where groups with thousands of members share “before and after” photos, injection guides and assertions of rapid British shipping. Vendors promote the drug there before redirecting customers to WhatsApp for transactions.

Learning About Retatrutide

This medication is an experimental injection developed by US drugmaker Eli Lilly. The treatment targets three intestinal hormones – glucagon-like peptide-1, GIP and pancreatic hormone. Early trials indicate it could help patients reduce up to 25% of their total weight. Nicknamed the “triple G”, the substance is being promoted online as the next Ozempic.

Medical Experts Express Concerns

However, doctors and pharmacists have cautions that the sale of what remains an unapproved drug in the UK is a cause for concern and could result in individuals administering products of uncertain source.

Some experts said the demand for the experimental drug could be connected to the increasing price of licensed slimming products such as Mounjaro.

Legal Status and Implementation

Marketing retatrutide on TikTok or Telegram is illegal in the UK, as it is an unapproved drug that must not be promoted or supplied for human use under the Human Medicines Regulations 2012.

Several content creators attempt to sidestep the regulations by calling to the substance as a “research chemical” or citing it as “not for human consumption”. Retatrutide is not a restricted drug, but advertising and supply can still violate medicines, advertising, and customer regulations, potentially leading to penalties, prosecution or imprisonment.

Service Response and Content Elimination

According to the social media company, the service has removed problematic content and banned associated keywords and query recommendations. The company stated it was committed to maintaining the platform secure and investing in enhancing enforcement strategies.

Online Trading Activities

Research also found groups with up to 9,000 participants marketing retatrutide using the platform's built-in search feature, which functions like a public directory. Entering “retatrutide” immediately brings up channels with numerous of users, filled with photos of weight loss, glowing reviews and detailed instructions for mixing or administering at home.

After minutes of joining one community, a seller shared WhatsApp details, where the majority of transactions take place. The seller sent an instruction manual and guaranteed delivery within 48 hours. When asked whether the product was authentic, one vendor said: “You can’t be sure.” Another provided a image of a alleged testing documentation. Not one inquired about body mass, medical conditions or previous experience.

Product Information and Pricing

Within these groups, posts display dark colored parcels with Royal Mail labels, stating to contain fresh supplies. One message read: “It took eight of us to load them this morning.”

Buyers can select between powder vials, prepared at residence with sterile water, or ready-to-use injectors typically sold at £160 for 20mg. When questioned how long a injector should be used, sellers give contradictory answers varying between a few weeks to “depends on your body”.

Platform Oversight and Safety Actions

A representative for the messaging service said it regularly monitored harmful material on its service including material that encouraged the “misuse of controlled medications”. The company added that it removed “millions of pieces of harmful content each day”.

Medical Professional Warnings

“Individuals are injecting substances they can’t verify. Although the science behind this drug is sound, these digital versions may not include what they advertise,” said a pharmacy expert, the director of pharmaceutical services at Chemist4U.

Dr Crystal Wyllie of Asda Online Doctor linked the surge in demand to recent price rises for approved slimming drugs such as Mounjaro. “With costs rising, individuals are using social media. But counterfeit treatments are highly risky. You can’t be certain what’s contained or whether the conditions they were produced in was sterile,” she explained.

Her team has previously seen individuals harmed by self-injection from unverified suppliers. “We understand the disappointment, but buying from messaging apps or communication platforms is gambling with your well-being,” stated the doctor. “These materials could be impure or improperly measured.”

Producer Position

A representative from the pharmaceutical company said retatrutide was in third stage clinical trials and had not been reviewed or authorized by any government authority globally. “Therefore at this point no one can sell [it] for human use,” they explained, adding that any product “misleadingly claiming itself as a Lilly experimental substance not yet approved … may subject users to potentially serious health risks”.